riboflavin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases colorectal cancer incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“After fully adjusting for the confounding factors, an increased risk of colorectal cancer was suggested for individuals with higher levels of serum riboflavin (OR = 1.08 (1.01, 1.15), p = 0.03) in a dose-response relationship.”
Quoted verbatim from High serum riboflavin is associated with the risk of sporadic colorectal cancer.. - Study
- case-control
- Population
- Adults at one Shanghai hospital: sporadic colorectal cancer patients without family history and healthy controls; exposure is endogenous serum riboflavin level, not an administered dose
Effect 1.08 odds ratio, 95% CI 1.01 to 1.15
High serum riboflavin is associated with the risk of sporadic colorectal cancer.2023PMID:36863217Permalink
Keep reading
- Everything the graph holds on riboflavin
- Every compound studied against Colorectal cancer incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5RXHJCPYWYR3SD01RWV6RGP